Tenet Healthcare Corporation (THC) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $196.60. It has a SharesGrow Score of 69/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of THC = $535.37 (+172.3% from the current price, the stock appears undervalued). Analyst consensus target is THC = $259 (+31.5% upside).
Valuation: THC trades at a trailing Price-to-Earnings (P/E) of 12.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 5.35.
Financials: revenue is $21.3B, +3.6%/yr average growth. Net income is $1.4B, growing at +109.6%/yr. Net profit margin is 6.6% (thin). Gross margin is 41.4% (-41.5 pp trend).
Balance sheet: total debt is $13.2B against $4.2B equity (Debt-to-Equity (D/E) ratio 3.12, leveraged). Current ratio is 1.76 (strong liquidity). Debt-to-assets is 44.4%. Total assets: $29.7B.
Analyst outlook: 25 / 32 analysts rate THC as buy (78%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 49/100 (Partial), Growth 73/100 (Pass), Past 100/100 (Pass), Health 67/100 (Partial), Moat 62/100 (Partial), Future 85/100 (Pass), Income 45/100 (Partial).
